celecoxib has been researched along with Obesity in 13 studies
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| " We evaluated rates of acute kidney injury (AKI) in primary and revision TJA using a multimodal pain control regimen including scheduled celecoxib and PRN ketorolac." | 7.83 | Risk of Acute Kidney Injury After Primary and Revision Total Hip Arthroplasty and Total Knee Arthroplasty Using a Multimodal Approach to Perioperative Pain Control Including Ketorolac and Celecoxib. ( Callaghan, JJ; Hogue, MH; Klaassen, AL; Liu, SS; Noiseux, NO; Warth, LC, 2016) |
| "We investigated the effects of metformin and celecoxib on obesity-induced adipose tissue inflammation, insulin resistance (IR), fatty liver, and high blood pressure in high-fat (HF) fed rats." | 7.83 | Additional effect of metformin and celecoxib against lipid dysregulation and adipose tissue inflammation in high-fat fed rats with insulin resistance and fatty liver. ( Hsieh, PS; Hung, YJ; Lu, CH, 2016) |
| " We evaluated rates of acute kidney injury (AKI) in primary and revision TJA using a multimodal pain control regimen including scheduled celecoxib and PRN ketorolac." | 3.83 | Risk of Acute Kidney Injury After Primary and Revision Total Hip Arthroplasty and Total Knee Arthroplasty Using a Multimodal Approach to Perioperative Pain Control Including Ketorolac and Celecoxib. ( Callaghan, JJ; Hogue, MH; Klaassen, AL; Liu, SS; Noiseux, NO; Warth, LC, 2016) |
| "We investigated the effects of metformin and celecoxib on obesity-induced adipose tissue inflammation, insulin resistance (IR), fatty liver, and high blood pressure in high-fat (HF) fed rats." | 3.83 | Additional effect of metformin and celecoxib against lipid dysregulation and adipose tissue inflammation in high-fat fed rats with insulin resistance and fatty liver. ( Hsieh, PS; Hung, YJ; Lu, CH, 2016) |
| " The whole body insulin resistance of HFa indicated by the increased fasting plasma insulin levels and the elevated area under curve of insulin obtained from the oral glucose tolerance test were significantly reversed in those combined with celecoxib and nimesulid administration compared with those in HFr." | 3.77 | The importance of cyclooxygenase 2-mediated oxidative stress in obesity-induced muscular insulin resistance in high-fat-fed rats. ( Chen, CH; Hsia, TL; Hsieh, CH; Hsieh, PS; Huang, DW; Tian, YF, 2011) |
| " After treatment with celecoxib, the hypertension was attenuated (MAP=126±2 mm Hg) in obese rats without changes in HR." | 3.76 | Cox-2 inhibition attenuates cardiovascular and inflammatory aspects in monosodium glutamate-induced obese rats. ( Cecchini, R; Cunha, NV; de Abreu, SB; Grassiolli, S; Guarnier, FA; Martins-Pinge, MC; Mazzuco, TL; Panis, C; Pinge-Filho, P, 2010) |
| "Treatment with celecoxib resulted in G1 cell cycle arrest, induction of apoptosis, inhibition of cellular adhesion and invasion and reduction of expression of hTERT mRNA and COX-2 protein in all of the ovarian cancer cell lines." | 1.43 | The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer. ( Bae-Jump, VL; Gehrig, PA; Han, X; Jones, HM; Schuler, KM; Sheng, X; Suri, A; Zhong, Y; Zhou, C, 2016) |
| "Body weight was increased significantly and similarly in HFa, HFa-Cel, and HFa-Mes." | 1.35 | COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver. ( Chan, PC; Chen, CH; Chiang, CF; Hsieh, PS; Jin, JS; Shih, KC, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 10 (76.92) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Ghazala, RA | 1 |
| El Medney, A | 1 |
| Meleis, A | 1 |
| Mohie El Dien, P | 1 |
| Samir, H | 1 |
| Latif, D | 1 |
| Darweesh, FF | 1 |
| Osman, OM | 1 |
| Abdelhakim, AM | 1 |
| Nabil, H | 1 |
| Ashour, ASA | 1 |
| Kurhe, Y | 1 |
| Mahesh, R | 1 |
| Gupta, D | 1 |
| Warth, LC | 1 |
| Noiseux, NO | 1 |
| Hogue, MH | 1 |
| Klaassen, AL | 1 |
| Liu, SS | 1 |
| Callaghan, JJ | 1 |
| Suri, A | 1 |
| Sheng, X | 1 |
| Schuler, KM | 1 |
| Zhong, Y | 1 |
| Han, X | 1 |
| Jones, HM | 1 |
| Gehrig, PA | 1 |
| Zhou, C | 1 |
| Bae-Jump, VL | 1 |
| Lu, CH | 1 |
| Hung, YJ | 1 |
| Hsieh, PS | 4 |
| Jin, JS | 1 |
| Chiang, CF | 2 |
| Chan, PC | 1 |
| Chen, CH | 3 |
| Shih, KC | 1 |
| Lu, KC | 1 |
| Cunha, NV | 1 |
| de Abreu, SB | 1 |
| Panis, C | 1 |
| Grassiolli, S | 2 |
| Guarnier, FA | 1 |
| Cecchini, R | 1 |
| Mazzuco, TL | 1 |
| Pinge-Filho, P | 2 |
| Martins-Pinge, MC | 2 |
| Tian, YF | 1 |
| Hsia, TL | 1 |
| Hsieh, CH | 1 |
| Huang, DW | 1 |
| da Cunha, NV | 1 |
| Barbosa Neto, O | 1 |
| Le, P | 1 |
| Kawai, M | 1 |
| Bornstein, S | 1 |
| DeMambro, VE | 1 |
| Horowitz, MC | 1 |
| Rosen, CJ | 1 |
| Blackler, R | 1 |
| Syer, S | 1 |
| Bolla, M | 1 |
| Ongini, E | 1 |
| Wallace, JL | 1 |
1 trial available for celecoxib and Obesity
| Article | Year |
|---|---|
Oral tramadol versus oral celecoxib for analgesia after mediolateral episiotomy repair in obese primigravidae: a randomized controlled trial.
Topics: Analgesia; Analgesics, Opioid; Celecoxib; Double-Blind Method; Episiotomy; Female; Humans; Obesity; | 2021 |
12 other studies available for celecoxib and Obesity
| Article | Year |
|---|---|
Role of anti-inflammatory interventions in high-fat-diet-induced obesity.
Topics: Animals; Anti-Inflammatory Agents; Celecoxib; Cytokines; Diet, High-Fat; Disease Models, Animal; Fat | 2020 |
Effect of a selective cyclooxygenase type 2 inhibitor celecoxib on depression associated with obesity in mice: an approach using behavioral tests.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Celecoxib; Cyclooxygenase 2 Inhibitors; Depression | 2014 |
Risk of Acute Kidney Injury After Primary and Revision Total Hip Arthroplasty and Total Knee Arthroplasty Using a Multimodal Approach to Perioperative Pain Control Including Ketorolac and Celecoxib.
Topics: Acute Kidney Injury; Anti-Inflammatory Agents, Non-Steroidal; Arthroplasty, Replacement, Hip; Arthro | 2016 |
The effect of celecoxib on tumor growth in ovarian cancer cells and a genetically engineered mouse model of serous ovarian cancer.
Topics: Animals; Apoptosis; BRCA1 Protein; Celecoxib; Cell Adhesion; Cell Cycle; Cell Line, Tumor; Cell Prol | 2016 |
Additional effect of metformin and celecoxib against lipid dysregulation and adipose tissue inflammation in high-fat fed rats with insulin resistance and fatty liver.
Topics: Adipocytes; Adipokines; Adipose Tissue; AMP-Activated Protein Kinases; Animals; Blood Pressure; Body | 2016 |
COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver.
Topics: Adipocytes; Adipogenesis; Adipose Tissue; Animals; Blood Glucose; Body Weight; Celecoxib; Cell Size; | 2009 |
Suppressive effect of COX2 inhibitor on the progression of adipose inflammation in high-fat-induced obese rats.
Topics: Adiposity; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Blood Glucose; Blood Pr | 2010 |
Cox-2 inhibition attenuates cardiovascular and inflammatory aspects in monosodium glutamate-induced obese rats.
Topics: Adipose Tissue; Animals; Blood; Blood Pressure; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibi | 2010 |
The importance of cyclooxygenase 2-mediated oxidative stress in obesity-induced muscular insulin resistance in high-fat-fed rats.
Topics: Adipose Tissue; Animals; Biomarkers; Celecoxib; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Diet, R | 2011 |
COX-2 inhibition does not reverse the increased sympathetic modulation in MSG obese rats.
Topics: Animals; Blood Pressure; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Food Additives; H | 2011 |
A high-fat diet induces bone loss in mice lacking the Alox5 gene.
Topics: Animals; Arachidonate 5-Lipoxygenase; Bone Density; Bone Resorption; Celecoxib; Cyclooxygenase 2; Cy | 2012 |
Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Aspirin; Celecoxib; Drug Therapy, Combi | 2012 |